Finasteride Tablet, Film Coated
Product Images NDC 31722-525

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 31722-525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteridetab5mg30slabel (Finasteridetab5mg30slabel)

Finasteride 5 mg film-coated oral tablets label from Camber Pharmaceuticals, Inc. The label includes the NDC 31722-525-30, indicates 30 tablets per container, and states prescription use only. It provides storage instructions, a warning against use by women and children, and specifies usual adult dosage as 5 mg once daily. Manufactured by Camber Pharmaceuticals, Inc. in Piscataway, NJ.*

FDA Label Image

Finasteridetab5mg30slabel2 (Finasteridetab5mg30slabel2)

Finasteride Tablets USP 5 mg film-coated tablets label from Camber Pharmaceuticals, Inc. The label indicates a package containing 30 tablets. It includes storage instructions, warnings, and manufacturing information, displaying the NDC 31722-525-30 barcode and batch coding area.*

FDA Label Image

Finasteridetab5mg90slabel (Finasteridetab5mg90slabel)

Finasteride Tablets, USP 5 mg film-coated tablets in a label from Camber Pharmaceuticals, Inc. The label includes storage instructions at 20° to 25°C and warnings against use by women or children, especially those who may be pregnant. The package contains 90 tablets and is marked Rx Only. It also notes distribution by Hetero Labs Limited, Hyderabad, India.*

FDA Label Image

Finasteridetab5mg90slabel2 (Finasteridetab5mg90slabel2)

Finasteride Tablets, USP 5 mg film-coated tablets carton label by Camber Pharmaceuticals, Inc. The package contains 90 tablets for oral use. The label includes storage instructions, a warning against use by women or children, and details of manufacture including Hetero Labs Limited, India. Barcodes and batch coding areas are also present.*

FDA Label Image

Address.jpg (Address)

FDA Label Image

Address3.jpg (Address3)

FDA Label Image

Figure1.jpg (Figure1)

A line graph comparing the mean change from baseline over four years between Finasteride 5 mg oral tablets and placebo groups. The graph shows a marked decrease in mean change for the Finasteride group compared to placebo, with data points at baseline, year 1, year 2, year 3, and year 4, including sample sizes for each time point.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph titled 'Figure 2 Percent of Patients Having Surgery for BPH, Including TURP' comparing the percentage of patients undergoing surgery over time between Finasteride and placebo groups. The x-axis shows observation time in months (0 to 48), and the y-axis shows the percent of patients (0% to 15%). Two lines illustrate trends: one for Finasteride and one for placebo, with placebo showing a higher percentage of surgeries over time.*

FDA Label Image

Figure3.jpg (Figure3)

A line graph depicting the mean percent change from baseline ± 1 standard error over four years comparing placebo and finasteride. The graph shows two lines representing the placebo group and the finasteride group with sample sizes listed for each year. The vertical axis shows percent change, and the horizontal axis shows time points from baseline through Year 4.*

FDA Label Image

Figure4.jpg (Figure4)

A line graph depicting the percentage of events over years from randomization for four groups: Placebo, Finasteride, Doxazosin, and Combination. The x-axis represents years (0 to 5.5), and the y-axis shows the percent with events, ranging approximately from 0 to 25%. Each group is represented by a distinct line and symbol.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of Finasteride depicted as a steroidal molecule with a four-ring core and functional groups including ketone and amide groups. The structure shows hydrogen atoms, methyl groups, and a nitrogen atom as part of the amide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.